Skip to main content
Equibles

Frazier Life Sciences Management, L.P.

Position in ALLO — Allogene Therapeutics, Inc.

CIK 1892134 PALO ALTO, CA
Back to ALLO Full portfolio

Position in ALLO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$46,689,069
+$37,425,200 QoQ
Shares Held
22,446,668
+491.2% QoQ
Ownership
6.50%
of shares outstanding
% of Portfolio
1.02%
of 13F equity value
Holder Rank
#2
of 209 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALLO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Frazier Life Sciences Management, L.P. holds $4,497,017,185 across 37 Biotechnology names. ALLO ranks #21 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MIRM
Mirum Pharmaceuticals, Inc.
 7,679,684 $899,060,605
2 NAMS
NewAmsterdam Pharma Co N.V.
 18,589,235 $623,725,004
3 ERAS
Erasca, Inc.
 24,975,188 $457,545,444
4 MBX
MBX Biosciences, Inc.
 6,652,013 $367,191,117
5 ARQT
Arcutis Biotherapeutics, Inc.
 9,874,511 $258,909,678
6 TRVI
Trevi Therapeutics, Inc.
 9,939,447 $185,370,686
7 KRYS
Krystal Biotech, Inc.
 481,307 $178,887,372
8 MAZE
Maze Therapeutics, Inc.
 5,032,915 $150,182,183

All Filings in ALLO

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $46,689,069 22,446,668
2026-03-31 $9,263,869 3,796,668
2025-12-31 $5,300,187 3,868,750
2025-09-30 $4,797,250 3,868,750
2025-06-30 $4,371,687 3,868,750
2025-03-31 $5,648,375 3,868,750
2024-12-31 $6,108,307 2,867,750
2024-09-30 $8,029,700 2,867,750
2024-06-30 $6,681,857 2,867,750
2024-03-31 $12,818,842 2,867,750